Charles Theuer - 05 Nov 2021 Form 4 Insider Report for Tracon Pharmaceuticals, Inc.

Role
President and CEO, Director
Signature
/s/ Scott B. Brown, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
05 Nov 2021
Net transactions value
+$13,655
Form type
4
Filing time
09 Nov 2021, 06:00:11 UTC
Previous filing
18 Aug 2021
Next filing
22 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCON Common Stock Purchase $3,410 +1,000 +0.47% $3.41 212,137 05 Nov 2021 Direct F1
transaction TCON Common Stock Purchase $10,245 +3,000 +1.4% $3.42 215,137 05 Nov 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 3,405 shares acquired by the Reporting Person under the Issuer's 2015 Employee Stock Purchase Plan on October 20, 2021.